Abstract

免疫检查点抑制剂(immune checkpoint inhibitors, ICIs)是一种负性调节因子抗体,激活T细胞发挥免疫治疗抗肿瘤作用的同时,也可引起免疫相关的不良应答,从而诱导出一系列免疫相关不良反应(immune related adverse events, irAEs)。在这些irAEs中,ICIs相关心肌炎的发病率虽然很低,但致死率却明显高于其他不良反应,接近50%,临床医生应用ICIs时应提高警惕,但目前ICIs相关心肌炎的发病机制仍不明确。本文结合近期ICIs的研究成果对ICIs相关性心肌炎的发生机制及临床表现等方面作一综述,以提高临床医生对该不良反应的认识。

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.